Overview

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Rosuvastatin Calcium